Traws Pharma (TRAW) Other Non-Current Liabilities (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Other Non-Current Liabilities of $259000.0 for Q1 2026, up 68.18% year-over-year from $154000.0 in Q1 2025, and up 159.0% quarter-over-quarter from $100000.0 in Q4 2025.
Traws Pharma (TRAW) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Other Non-Current Liabilities for 12 consecutive years, with $259000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 68.18% year-over-year to $259000.0; the TTM figure through Mar 2026 stood at $259000.0 (up 68.18% YoY), while the FY2025 annual figure was $100000.0, down 99.76% from the prior year.
- Other Non-Current Liabilities climbed to $259000.0 in Q1 2026 per TRAW's latest filing, from $100000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $42.5 million in Q4 2024 and bottomed at $8000.0 in Q2 2025.
- Historically, Other Non-Current Liabilities has averaged $7.2 million across 3 years, with a median of $127000.0 in 2025.
- Annual changes were most pronounced in 2025 — Other Non-Current Liabilities sank 99.76% — and 2026, when it jumped 68.18%.
- Traws Pharma's Other Non-Current Liabilities stood at $42.5 million in 2024, then tumbled by 99.76% to $100000.0 in 2025, then surged by 159.0% to $259000.0 in 2026.
- Business Quant data shows TRAW's Other Non-Current Liabilities at $259000.0 in Q1 2026, $100000.0 in Q4 2025, and $11000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 259,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Dec 31, 2024 | 42.49 Mn |
| Jun 30, 2021 | 530,000.00 |
| Mar 31, 2021 | 636,000.00 |
| Dec 31, 2020 | 321,000.00 |
| Sep 30, 2020 | 176,000.00 |
| Jun 30, 2020 | 232,000.00 |
| Mar 31, 2020 | 176,000.00 |
| Dec 31, 2019 | 113,000.00 |
| Sep 30, 2019 | 96,000.00 |
| Jun 30, 2019 | 571,000.00 |
| Mar 31, 2019 | 603,000.00 |
| Dec 31, 2018 | 176,000.00 |
| Sep 30, 2018 | 319,000.00 |
| Jun 30, 2018 | 448,000.00 |
| Mar 31, 2018 | 961,000.00 |